Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
How transcription factors work together in cancer formation
A new study co-authored by University of Colorado Cancer Center (USA) researcher Srinivas Ramachandran, PhD,…
Promising new therapy for inoperable brain cancers
Magnetic nanoparticle could be used in combination with radiation treatment and heat therapy to kill…
Understanding how DNA repairs itself may lead to better cancer treatment
From cancer treatment to sunlight, radiation and toxins can severely damage DNA in both harmful…
The importance of returning results to study participants
Researchers from Garvan and the Australian Pancreatic Cancer Genome Initiative have explored the feasibility and value of returning the results…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.